Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | UBE2N | P61088 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28696485 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL15239749 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL30368691 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL2727470 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL30432362 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL898809 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL5718656 | 1.00 | MEN1 (0.57) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL4550651 | 0.98 | MEN1 (0.54) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL6237363 | 0.91 | KDM4E (0.67) | MEN1KMT2AKDM4EASAH1ALDH1A1 | |
| SCHEMBL8815031 | 0.91 | KDM4E (0.67) | MEN1KMT2AKDM4EASAH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638991-B1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION FOR REDUCING THE SIGNS OF CUTANEOUS AGEING | SEDERMA SA (FR) | 2017-08-02 | — | — | EP | claimed |
| US-20090186826-A1 | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides | SEDERMA (FR) | 2009-07-23 | — | — | US | claimed |
| EP-1638991-B1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION FOR REDUCING THE SIGNS OF CUTANEOUS AGEING | SEDERMA SA (FR) | 2017-08-02 | — | — | EP | disclosed |
| US-20090186826-A1 | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides | SEDERMA (FR) | 2009-07-23 | — | — | US | disclosed |
| US-20040120918-A1 | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides | SEDERMA S.A.S. (FR) | 2004-06-24 | — | — | US | disclosed |
| EP-0373038-B1 | New lysosphingolipid derivatives | FIDIA SPA (IT) | 1997-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186826-A1 | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides | SGMS1, CERS2, SGMS2 | MEN1 1454/4885KMT2A 4509/4885KDM4E 4502/4885 |
| US-20040120918-A1 | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides | SGMS1, CERS2, SGMS2 | MEN1 1454/4885KMT2A 4509/4885KDM4E 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.